AU Stock MarketDetailed Quotes
NEU Neuren Pharmaceuticals Ltd
- 20.680
- -0.100-0.48%
20min DelayMarket Closed Jul 19 16:00 AET
2.69BMarket Cap17.22P/E (Static)
20.740High20.010Low248.10KVolume20.500Open20.780Pre Close5.10MTurnover25.95052wk High0.22%Turnover Ratio130.07MShares10.02052wk Low1.201EPS TTM2.29BFloat Cap65.000Historical High17.22P/E (Static)110.82MShs Float0.060Historical Low1.201EPS LYR3.51%Amplitude--Dividend TTM13.11P/B1Lot Size--Div YieldTTM
About Neuren Pharmaceuticals Ltd Company
Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products.
Company Profile
SymbolNEU
Company NameNeuren Pharmaceuticals Ltd
Founded2004
MarketASX
Employees11
Fiscal Year Ends12-31
Address697 Burke Road Suite 201
CityMelbourne
CountryAustralia
Zip Code3124
Phone+61 390920480
Websitehttps://www.neurenpharma.com
Share RegistryLINK MARKET SERVICES LIMITED
Tower 4, 727 Collins Street, DOCKLANDS, VIC, AUSTRALIA, 3008
1300 554 474
Company Executives
- Name
- Position
- Salary
- Jonathan Pilcher
- Director, Chief Executive Officer and Managing Director
- --
- Patrick Donald Davies, M.B.A.
- Non-Executive Chairman of the Board
- --
- Dr. Trevor Scott
- Independent Director
- --
- Dr. Jenny Harry
- Independent Director
- --
- Dianne Angus
- Independent Director
- --
- Joe Basile
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg